Literature DB >> 29786087

A comparison of 23-gauge and 20-gauge vitrectomy for proliferative sickle cell retinopathy - clinical outcomes and surgical management.

Jason Ho1, Anna Grabowska1, Marta Ugarte2,3, Mahiul Mk Muqit4,5.   

Abstract

AIMS: To report anatomical and functional outcomes in patients with proliferative sickle retinopathy (PSR) who underwent 23-gauge (23G) and 20-gauge (20G) vitrectomy.
METHODS: Retrospective consecutive case series of patients who underwent vitreoretinal intervention for complications of PSR between April 2009 and February 2015. Operations were performed at a tertiary referral centre, Moorfields Eye Hospital. Visual acuity and anatomical success rates were evaluated for PSR complicated by retinal detachment, tractional vitreous haemorrhage and macular hole. Proliferative diabetic retinopathy cases were excluded.
RESULTS: A total of 71 eyes (63 patients) underwent vitreoretinal surgery for PSR complications with 26 months mean follow-up. Primary indications were: tractional retinal detachment (TRD, n = 17), TRD with rhegmatogenous retinal detachment (n = 16), rhegmatogenous retinal detachment (n = 5, macula-on: 1, macula-off: 4), vitreous haemorrhage (n = 19), epiretinal membrane (n = 6), and full thickness macula hole (n = 8). Thirty-nine cases underwent 20G vitrectomy, and 23G surgery was performed in 32 eyes. Mean best corrected visual acuity (BCVA) improved from pre-operative 1.30 LogMAR to final BCVA of 0.74 LogMAR (p < 0.01, paired t-test). 23G vitrectomy yielded slightly better 32 vs. 25 ETDRS-letter improvement compared with 20G vitrectomy (p = 0.60, NS, unpaired t-test). 23G was associated with fewer per-operative complications (23G, 18% vs. 20G,13%). The subset of 38 eyes with retinal detachment demonstrated 79% primary reattachment rate, and a smaller BCVA improvement of 3 lines (p = 0.07, paired t-test).
CONCLUSIONS: Surgical intervention for complicated PSR can preserve and/or improve vision although the degree of visual acuity stabilisation remains guarded in tractional/rhegmatogenous detachments. 23G vitrectomy may give a better functional outcome with lower per-operative complication rates.

Entities:  

Mesh:

Year:  2018        PMID: 29786087      PMCID: PMC6137034          DOI: 10.1038/s41433-018-0127-y

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  11 in total

Review 1.  Sickle cell disease and the eye: old and new concepts.

Authors:  Mohammed Elagouz; Sreedhar Jyothi; Bhaskar Gupta; Sobha Sivaprasad
Journal:  Surv Ophthalmol       Date:  2010-05-10       Impact factor: 6.048

2.  Spatial and spectral imaging of retinal laser photocoagulation burns.

Authors:  Mahiul M K Muqit; Jonathan Denniss; Vincent Nourrit; George R Marcellino; David B Henson; Ingo Schiessl; Paulo E Stanga
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-23       Impact factor: 4.799

3.  Pars plana vitrectomy in the management of complications of proliferative sickle retinopathy.

Authors:  J S Pulido; H W Flynn; J G Clarkson; G W Blankenship
Journal:  Arch Ophthalmol       Date:  1988-11

4.  An update on vitrectomy surgery and retinal detachment repair in sickle cell disease.

Authors:  L M Jampol; J L Green; M F Goldberg; G A Peyman
Journal:  Arch Ophthalmol       Date:  1982-04

5.  Vitreoretinal management and surgical outcomes in proliferative sickle retinopathy: a case series.

Authors:  Royce W S Chen; Harry W Flynn; Wen-Hsiang Lee; D Wilkin Parke; Ryan F Isom; Janet L Davis; William E Smiddy
Journal:  Am J Ophthalmol       Date:  2013-12-31       Impact factor: 5.258

Review 6.  Sickle-cell disease.

Authors:  David C Rees; Thomas N Williams; Mark T Gladwin
Journal:  Lancet       Date:  2010-12-03       Impact factor: 79.321

7.  Spatial changes of central field loss in diabetic retinopathy after laser.

Authors:  Yanfang Wang; Mahiul M K Muqit; Paulo E Stanga; Lorna B Young; David B Henson
Journal:  Optom Vis Sci       Date:  2014-01       Impact factor: 1.973

8.  Vitreoretinal management of the complications of sickle cell retinopathy by observation or pars plana vitrectomy.

Authors:  T H Williamson; R Rajput; D A H Laidlaw; B Mokete
Journal:  Eye (Lond)       Date:  2008-10-03       Impact factor: 3.775

9.  Patterns of visual loss in untreated sickle cell retinopathy.

Authors:  B J Moriarty; R W Acheson; P I Condon; G R Serjeant
Journal:  Eye (Lond)       Date:  1988       Impact factor: 3.775

Review 10.  Laser therapy for retinopathy in sickle cell disease.

Authors:  Kay Thi Myint; Soumendra Sahoo; Aung Win Thein; Soe Moe; Han Ni
Journal:  Cochrane Database Syst Rev       Date:  2015-10-09
View more
  3 in total

1.  Action on sickle cell retinopathy: the time is now.

Authors:  Christiana Dinah; Brigit Greystoke; Isabella Mueller; James Talks
Journal:  Eye (Lond)       Date:  2022-01-28       Impact factor: 4.456

Review 2.  Surgical and Medical Perioperative Management of Sickle Cell Retinopathy: A Literature Review.

Authors:  Harrish Nithianandan; Jayanth Sridhar
Journal:  Int Ophthalmol Clin       Date:  2020

3.  Comparison of postoperative ciliary body changes associated with the use of 23-gauge and 20-gauge system for pars plana vitrectomy.

Authors:  Meng-Su Tang; Shu-Qi Zhang; Li-Wei Ma
Journal:  BMC Ophthalmol       Date:  2018-10-11       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.